# Cascade Biocatalysts

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cascade-biocatalysts

- Industry: Chemicals
- Headquarters: Denver, US
- Website: www.cascadebiocatalysts.com
- Total disclosed funding: $5.4M
- Latest round: Seed (Aug 8, 2025)
- Investors on record: 6

## About

Founded in 2022 and based in Colorado, U.S., by co-founders James Weltz and Alex Rosay, Cascade Biocatalysts, Inc. specializes in the development and production of biocatalysts for various industries. In August 2023, Cascade Biocatalysts, Inc. raised USD 2.6 million in pre-seed funding led by investor Ten VC, with participation from other investors Amplify.LA, Boost VC, Cool Climate Collective, Range Ventures, and Spacecadet Ventures.
 
Cascade Biocatalysts offers a long-lasting biocatalyst platform that leverages enzymes to catalyze chemical reactions with high precision and efficiency. By utilizing enzymes derived from natural sources, Cascade Biocatalysts, Inc. provides a sustainable alternative to conventional chemical synthesis methods. Their products find applications across industries, enabling the creation of a wide range of chemicals that serve as essential building blocks for countless manufactured goods.
 
The company plans to use the August 2023 funding to scale enzymes for biomanufacturing and support its customer base.

## Funding rounds

- Seed, Aug 8, 2025, $5.4M — Amplify, Endurance28, Stray Dog Capital, Range Ventures, 1Flourish Capital, 10vc

## Investors

- Amplify (https://capitalatlas.ai/funds/amplify) — Seed
- Endurance28 (https://capitalatlas.ai/funds/endurance28) — Seed
- Stray Dog Capital (https://capitalatlas.ai/funds/stray-dog-capital) — Seed
- Range Ventures (https://capitalatlas.ai/funds/range-ventures) — Seed
- 1Flourish Capital (https://capitalatlas.ai/funds/1flourish-capital) — Seed
- 10vc (https://capitalatlas.ai/funds/10vc) — Seed